Boehringer Ingelheim partners with Constantia Flexibles to provide augmented reality packaging experience

Ingelheim, Germany, 4 June 2019  – Boehringer Ingelheim has partnered with Constantia Flexibles to provide veterinarians and horse owners with Constantia Interactive, an innovative packaging solution which enhances the Nutraxin packaging with augmented reality features. This packaging solution is currently available in Germany and the Netherlands; a rollout to further markets is planned in the coming months.

Constantia Interactive provides horse owners with direct access to a dedicated Nutraxin app. Using the integrated diary, they can add details about the horse's physical condition and easily monitor the horse's weight. Additionally, tips for proper nutrition can be called up via the app which integrates links to further information. The ingredients of Nutraxin are also listed clearly and in detail.

“With Constantia Flexibles' interactive packaging, we can offer our customers an outstanding additional service. This app will allow the veterinarian as well as the owner to easily track the horse's weight and to keep an eye on the nutritional status of the horse,” says Ulrike Voigt, Global Brand Manager for Nutraxin at Boehringer Ingelheim.

Pierre-Henri Bruchon, EVP Pharma Division at Constantia Flexibles, adds: “This is a great new project with our long-term partner Boehringer Ingelheim. Constantia Interactive has added value, bringing Boehringer Ingelheim even closer to the end consumer.”

With this partnership, Boehringer Ingelheim reaffirms its ongoing focus on providing innovative solutions to its customers.

Boehringer Ingelheim Animal Health Business Unit

Boehringer Ingelheim is the second largest animal health business in the world, with net sales of almost 4 billion euros in 2018 and presence in more than 150 markets.

Across the globe, our 10,000 employees create the future of animal wellbeing through their daily work. We believe in prevention over treatment and therefore, we focus on developing innovative solutions in the field of vaccines, parasiticides and therapeutics. With a large portfolio of advanced, preventive healthcare products, tools and services, we support our customers in taking care of the health of their animals.

For more information visit: www.boehringer-ingelheim.com/animal-health/overview.

Constantia Flexibles

Constantia Flexibles is the world’s third largest producer of flexible packaging. Based on the guiding principle of ‘People, Passion, Packaging’, some 8,300 employees manufacture tailor-made packaging solutions at 38 sites in 16 countries. Many international companies and local market leaders from the consumer and pharma industries choose the sustainable and innovative products of Constantia Flexibles. www.cflex.com

Boehringer Ingelheim

Improving the health of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.

Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. In 2018, Boehringer Ingelheim achieved net sales of around 17.5 billion euros. R&D expenditure of almost 3.2 billion euros, corresponded to 18.1 per cent of net sales.

As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment.

More information about Boehringer Ingelheim can be found on www.boehringer-ingelheim.com or in our annual report: https://annualreport.boehringer-ingelheim.com.

Intended audiences:

This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where we do business.